Hesdorffer, DC, Ishihara, L, Mynepalli, L, Webb, DJ, Weil, J, Hauser, WA. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol
2012; 72: 184–91.
Hesdorffer, DC, Hauser, WA, Olafsson, E, Ludvigsson, P, Kjartansson, O. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol
2006; 59: 35–41.
Cristancho, P, Cristancho, MA, Baltuch, GH, Thase, ME, O'Reardon, JP. Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year. J Clin Psychiatry
2011; 72: 1376–82.
Kosel, M, Brockmann, H, Frick, C, Zobel, A, Schlaepfer, TE. Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex. Psychiatry Res
2011; 191: 153–9.
Lewy, AJ, Wehr, TA, Goodwin, FK, Newsome, DA, Markey, SP. Light suppresses melatonin secretion in humans. Science
1980; 210: 1267–9.
Lam, RW, Levitt, AJ, Levitan, RD, Enns, MW, Morehouse, R, Michalak, EE, et al The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. Am J Psychiatry
2006; 163: 805–12.
Westrin, A, Lam, RW. Seasonal affective disorder: a clinical update. Ann Clin Psychiatry
2007; 19: 239–46.
Golden, RN, Gaynes, BN, Ekstrom, RD, Hamer, RM, Jacobsen, FM, Suppes, T, et al The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry
2005; 162: 656–62.
Tuunainen, A, Kripke, DF, Endo, T. Light treatment for non-seasonal depression. Cochrane Database Syst Rev
2004; 2: CD004050.
Shirani, A, St Louis, EK. Illuminating rationale and uses for light therapy. J Clin Sleep Med
2009; 5: 155–63.
Burns, A, Allen, H, Tomenson, B, Duignan, D, Byrne, J. Bright light therapy for agitation in dementia: a randomized controlled trial. Int Psychogeriatr
2009; 21: 711–21.
Allen, NH, Kerr, D, Smythe, PJ, Martin, N, Osola, K, Thompson, C. Insulin sensitivity after phototherapy for seasonal affective disorder. Lancet
1992; 339: 1065–6.
Baxendale, S, O'Sullivan, J, Heaney, D. Bright light therapy as an add on treatment for medically intractable epilepsy. Epilepsy Behav
2012; 24: 359–64.
Schulz, KF. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ
2010; 340: 332.
Zigmond, AS, Snaith, RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand
1983; 67: 361–70.
Terman, M, Terman, JS. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr
2005; 10: 647–63.
Lee, TM, Chan, CC. Dose-response relationship of phototherapy for seasonal affective disorder: a meta-analysis. Acta Psychiatr Scand
1999; 99: 315–23.
Wirz-Justice, A, Bucheli, C, Graw, P, Kielholz, P, Fisch, HU, Woggon, B. Light treatment of seasonal affective disorder in Switzerland. Acta Psychiatr Scand
1986; 74: 193–204.
Berson, DM, Dunn, FA, Takao, M. Phototransduction by retinal ganglion cells that set the circadian clock. Science
2002; 295: 1070–3.
Berson, DM. Strange vision: ganglion cells as circadian photoreceptors. Trends Neurosci
2003; 26: 314–20.
Meesters, Y, Dekker, V, Schlangen, LJ, Bos, EH, Ruiter, MJ. Low-intensity blue-enriched white light (750 lux) and standard bright light (10,000 lux) are equally effective in treating SAD. A randomized controlled study. BMC Psychiatry
2011; 11: 17.